유전자형 분석 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Genotyping Assay Market size is expected to reach USD 333.16 Billion in 2034 from USD 51.66 Billion (2025) growing at a CAGR of 23.01% during 2026-2034.

The global genotyping assay market is expanding rapidly due to the increasing use of genetic testing in medical research and disease diagnosis. Genotyping assays help identify genetic variations that influence disease susceptibility, drug response, and inherited conditions. These assays are widely used in clinical diagnostics, pharmaceutical research, and biotechnology applications.

The growth of the market is driven by advancements in genomic technologies and the rising demand for personalized medicine. Increasing research in genetics and the growing focus on early disease detection have significantly increased the adoption of genotyping assays. Additionally, government funding for genomic research and improvements in laboratory technologies are further supporting market development.

Looking ahead, the genotyping assay market is expected to witness strong growth as genomic medicine becomes more widely adopted. The integration of next-generation sequencing technologies and artificial intelligence in genetic analysis will enhance the accuracy and efficiency of genotyping tests. Expanding research in rare diseases and precision medicine will continue to create new opportunities for this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Reagents & Kits
• Genotyping Services
• Instruments
• Bioinformatics

By Technology

• PCR
• Microarrays
• Sequencing
• Capillary Electrophoresis
• MALDI-TOF
• Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)

By Application

• Pharmacogenomics
• Diagnostic & Personalized Medicine
• Agricultural Biotechnology
• Animal Genetics
• Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)

By End-user

• Pharmaceutical & Biopharmaceutical Companies
• Diagnostic & Research Laboratories
• Academic Institutes
• Others (Animal and Aquagenetics Companies, etc.)

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Agilent Technologies Inc, Danaher Corporation, F HoffmannLa Roche Ltd, GE HealthCare Technologies Inc, Standard BioTools Inc, PerkinElmer Inc, Eurofins Scientific SE, BioRad Laboratories Inc, Pacific Biosciences of California Inc, Genewiz Inc, Integrated DNA Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOTYPING ASSAY MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Genotyping Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOTYPING ASSAY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Capillary Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. MALDI-TOF Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOTYPING ASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Pharmacogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic & Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Agricultural Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Animal Genetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOTYPING ASSAY MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Pharmaceutical & Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic & Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others (Animal and Aquagenetics Companies, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENOTYPING ASSAY MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product & Service
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product & Service
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product & Service
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product & Service
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product & Service
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENOTYPING ASSAY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Illumina Inc
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 Qiagen N.V
  • 10.2.4 Agilent Technologies Inc
  • 10.2.5 Danaher Corporation
  • 10.2.6 F. Hoffmann-La Roche Ltd
  • 10.2.7 GE HealthCare Technologies Inc
  • 10.2.8 Standard BioTools Inc
  • 10.2.9 PerkinElmer Inc
  • 10.2.10 Eurofins Scientific SE
  • 10.2.11 Bio-Rad Laboratories Inc
  • 10.2.12 Pacific Biosciences Of California Inc
  • 10.2.13 Genewiz Inc
  • 10.2.14 Integrated DNA Technologies Inc